| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,838,000 | 3,495,000 | 3,378,000 | 3,475,000 | | Cost of Revenue | 2,830,000 | 2,648,000 | 2,495,000 | 2,801,000 | | | Gross Profit | 1,008,000 | 847,000 | 883,000 | 674,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 82,000 | 78,000 | 95,000 | 84,000 | | Non Recurring | 7,000 | 13,000 | (13,000) | (94,000) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 919,000 | 756,000 | 801,000 | 684,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 129,000 | 213,000 | 259,000 | (66,000) | | Earnings Before Interest And Taxes | 1,048,000 | 969,000 | 1,060,000 | 618,000 | | Interest Expense | 421,000 | 383,000 | 391,000 | 482,000 | | Income Before Tax | 627,000 | 586,000 | 669,000 | 136,000 | | Income Tax Expense | 205,000 | 105,000 | 175,000 | 49,000 | | Minority Interest | (255,000) | (511,000) |
-
| (148,000) | | | | Net Income From Continuing Ops | 951,000 | 20,000 | 501,000 | (66,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 19,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 185,000 | 20,000 | 501,000 | (47,000) | | Preferred Stock And Other Adjustments |
-
| 283,000 | (283,000) |
-
| | | Net Income Applicable To Common Shares | $185,000 | $303,000 | $218,000 | ($47,000) |
|
1.00% Nasdaq 
Income Statement
